BRCA1-associated protein-1 (BAP1) mutations

Clinical trials for BRCA1-associated protein-1 (BAP1) mutations explained in plain language.

Never miss a new study

Get alerted when new BRCA1-associated protein-1 (BAP1) mutations trials appear

Sign up with your email to follow new studies for BRCA1-associated protein-1 (BAP1) mutations, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1

Promising mesothelioma drug trial pulled before it even started

Disease control Cancelled

This study was designed to test the drug alrizomadlin (APG-115) in people with BAP1 cancer syndrome who have early-stage mesothelioma that does not yet need standard treatment. The goal was to see if the drug could stabilize or improve the disease. However, the trial was withdraw…

Matched conditions: BRCA1-ASSOCIATED PROTEIN-1 (BAP1) MUTATIONS

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 11:03 UTC

BRCA1-associated protein-1 (BAP1) mutations

Get alerted when new BRCA1-associated protein-1 (BAP1) mutations trials appear

Promising mesothelioma drug trial pulled before it even started